{"transactions":[{"id":1089084,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:38:48.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001062993-25-012726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000106299325012726/form4.xml","form_type":"4"}},{"id":1089083,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:38:48.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":56322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":56322},"source":{"system":"sec-edgar","filing":"0001062993-25-012726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000106299325012726/form4.xml","form_type":"4"}},{"id":1089082,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-10T20:38:48.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":30549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":11.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":30549},"source":{"system":"sec-edgar","filing":"0001062993-25-012726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000106299325012726/form4.xml","form_type":"4"}},{"id":1089081,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-10T20:38:48.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":16860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":21.95,"expiration_date":"2031-05-21","underlying":"Common Stock","underlying_shares":16860},"source":{"system":"sec-edgar","filing":"0001062993-25-012726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000106299325012726/form4.xml","form_type":"4"}},{"id":1089080,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-10T20:38:48.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":984513,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition of shares pursuant to that certain Amended and Restated Agreement and Plan of Merger dated as of April 28, 2025, as amended (the \"Merger Agreement\"), by and among Quanterix Corporation, a Delaware corporation (\"Quanterix\"), Wellfleet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Quanterix (\"Merger Sub\"), and Issuer. On July 8, 2025 (the \"Closing Date\"), Merger Sub merged with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Quanterix."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-25-012726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000106299325012726/form4.xml","form_type":"4"}},{"id":1489397,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:56:52.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 4, 2025, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.01,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-068748","document":"tm2416554-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000110465924068748/tm2416554-4_4seq1.xml","form_type":"4"}},{"id":1858247,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T18:16:44.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"shares":203388,"price":5,"value":1016940.0,"ownership":{"direct":true},"balance_after":984513,"source":{"system":"sec-edgar","filing":"0001104659-23-070481","document":"tm2318472-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000110465923070481/tm2318472-3_4seq1.xml","form_type":"4"}},{"id":1866066,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T17:54:10.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":56322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2024, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":56322,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":56322},"source":{"system":"sec-edgar","filing":"0001104659-23-068165","document":"tm2317841-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000110465923068165/tm2317841-2_4seq1.xml","form_type":"4"}},{"id":2243661,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2022-06-03T16:07:30.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":30549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2023, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":30549,"derivative":{"exercise_price":11.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":30549},"source":{"system":"sec-edgar","filing":"0001104659-22-068078","document":"tm2217652-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000110465922068078/tm2217652-6_4seq1.xml","form_type":"4"}},{"id":2696511,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2021-05-25T21:56:07.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":16860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) May 21, 2022, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":16860,"derivative":{"exercise_price":21.95,"expiration_date":"2031-05-21","underlying":"Common Stock","underlying_shares":16860},"source":{"system":"sec-edgar","filing":"0001104659-21-072014","document":"tm2117585-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652067/000110465921072014/tm2117585-5_4seq1.xml","form_type":"4"}},{"id":4610612,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":77558,"kind":"person","name":"Winkler Matthew","position":1,"cik":"0001652067","reported_name":"Winkler Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-06T22:25:41.000Z","date":"2016-06-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and become exercisable in full on the earlier of (A) June 29, 2017 or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":4.74,"expiration_date":"2026-06-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-16-078991","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527599/000114036116078991/doc1.xml","form_type":"4"}}]}